FdaApplication

ANDA 215902

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAUROBINDO PHARMA LTD
application_typeANDA
approval_date2023-06-14

Products (2)

ProductActive ingredientStrengthDosage form
SAFINAMIDE MESYLATESAFINAMIDE MESYLATEEQ 100MG BASETABLET;ORAL
SAFINAMIDE MESYLATESAFINAMIDE MESYLATEEQ 50MG BASETABLET;ORAL

2 products